| GeneLibs

题目:: [The utilization and limitation of CD133 epitopes in lung cancer stem cells research].
作者:: Chen(Yin),Zhong(Hong)
状态:: 发布时间2011-10-19 , 更新时间 2016-11-25
期刊:: Zhongguo Fei Ai Za Zhi
摘要:: Lung cancer is one of the most common tumor, which lacks of effective clinical treatment to lead to desirable prognosis. According to cancer stem cell hypothesis, lung cancer stem cells are considered to be responsible for carcinogenesis, development, metastasis, recurrence, invasion, resistance to chemotherapy and radiotherapy of lung cancer. In recent years, more and more institutes used glycosylated CD133 epitopes to define, isolate, purify lung cancer stem cells. However, along with deeply research, the application of CD133 epitopes in lung cancer stem cell research is questioned. The utilization and limitation of CD133 epitopes in lung cancer stem cells research for the past few years is summaried in this review.
语言:: chi
DOI:: 10.3779/j.issn.1009-3419.2011.10.10

文献库文献相关信息